Status:
WITHDRAWN
PET/MRI in Endometrial Cancer
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Cytoreductive Surgery
Grade 3 Endometrial Endometrioid Adenocarcinoma
Eligibility:
FEMALE
18-85 years
Phase:
NA
Brief Summary
This study is investigating if positron emission tomography (PET)/Magnetic resonance imaging (MRI) is more effective than the currently used imaging modalities (computed tomography \[CT\], or PET/CT) ...
Detailed Description
This research study involves undergoing a diagnostic imaging procedure called positron emission tomography/magnetic resonance imaging (PET/MRI). This type of scan uses a powerful magnet and a special ...
Eligibility Criteria
Inclusion
- Women aged 18-85 years old with an endometrial biopsy-confirmed diagnosis of either grade 3 endometrioid, serous, carcinosarcoma, undifferentiated or mixed cell carcinoma
- Must have presumed stage I disease, i.e., no symptoms suggesting disease outside of the uterus (weight loss, early satiety, bloating, changes in bowel movement, etc.)
- Planning to undergo cytoreductive surgery with a Gynecologic oncologist employed by Massachusetts General Hospital
- No previous history of chronic severe renal insufficiency and a glomerular filtration rate of \>30 mL/min/1.73m2. If the patient has a history of acute renal failure but their GFR as recovered to above 30,
Exclusion
- Weight greater than 300lbs (the PET/MRI table weight limit) or BMI \> 33
- Subjects less than 18 years of age or greater than 85 years of age
- Has Electrical implants, such as cardiac pacemakers or perfusion pumps
- Has Ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, prosthetic heart valves that are not compatible with the gradient maps of our scanners, metal fragments, shrapnel, metallic tattoos anywhere on the body, tattoos near the eye, or steel implants not compatible with a 3 Tesla MR.
- Is actively anticipating being pregnant or breastfeeding (a negative STAT quantitative serum hCG pregnancy test is required on the day of the scan before the subject can participate)
- Suffers from claustrophobia
- If research-related radiation exposure exceeds current Radiology Department guidelines (i.e., 50 mSv in the prior 12 months)
- Is unable to lie comfortably on a bed inside the PET/MRI bore as assessed by physical examination and medical history (e.g., back pain, arthritis)
- Subject is under the direct professional supervision of the principal investigator
- A history of chronic severe renal insufficiency (glomerular filtration rate \<30 mL/min/1.73m2)
- Perioperative liver transplantation period
Key Trial Info
Start Date :
March 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05390021
Start Date
March 30 2024
End Date
February 1 2026
Last Update
April 2 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.